Literature DB >> 25553494

Hypercalcemia and "primary" hyperparathyroidism during lithium therapy.

Howard I Shapiro1, Karina A Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25553494     DOI： 10.1176/appi.ajp.2013.13081057

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  5 in total

Review 1.  Lithium side effects and toxicity: prevalence and management strategies.

Authors:  Michael Gitlin
Journal:  Int J Bipolar Disord       Date:  2016-12-17

2.  Lithium-Associated Hypercalcemia Presenting with Neuropsychiatric Manifestations in a Patient with Bipolar Disorder.

Authors:  Roukaya Benjelloun; Imane Motaib; Yassine Otheman
Journal:  Case Rep Psychiatry       Date:  2020-12-10

3.  Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study.

Authors:  Umberto Albert; David De Cori; Andrea Aguglia; Francesca Barbaro; Fabio Lanfranco; Filippo Bogetto; Giuseppe Maina
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-20       Impact factor: 2.570

4.  Lithium-Associated Hypercalcemia: Pathophysiology, Prevalence, Management.

Authors:  Adrian D Meehan; Ruzan Udumyan; Mathias Kardell; Mikael Landén; Johannes Järhult; Göran Wallin
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

5.  Lithium-Associated Hyperparathyroidism Followed by Catatonia.

Authors:  Srinagesh Mannekote Thippaiah; Rachel E Fargason; Jayasudha G Gude; Shankarapura N Muralidhara; Badari Birur
Journal:  AACE Clin Case Rep       Date:  2020-12-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.